Jéhannin-Ligier Karine, Belot Aurélien, Guizard Anne-Valérie, Bossard Nadine, Launoy Guy, Uhry Zoé
Registre Général des Cancers de Lille et de sa Région, Centre de Référence Régional en Cancérologie, CHRU de LILLE, Hôpital Calmette - Pavillon Breton, Boulevard du Professeur Jules Leclercq, LILLE cedex, 59037, France.
Centre Hospitalier Lyon Sud, Service de biostatistiques des Hospices civils de Lyon, Pierre Benite, France.
Int J Cancer. 2017 May 1;140(9):2032-2039. doi: 10.1002/ijc.30631. Epub 2017 Feb 22.
Human papillomavirus (HPV) has been recently recognised as a carcinogenic factor for a subset of head and neck cancers (HNC). In Europe, France has one of the highest incidence rates of HNC. The aim of this study is to explore changes in HNC incidence in France, potentially in relation with infection by HPV. HNC were classified into two anatomical groups: potentially HPV-related and HPV-unrelated. Trends over the period 1980-2012 were analysed by an age-period-cohort model based on data from eleven French cancer registries. Among men, the age-standardised incidence rate (ASR) of HNC decreased in both groups, but less so for HPV-related sites as compared to unrelated sites, especially in recent years (annual percentage change [APC] over the period 2005-2012: -3.5% vs. -5.4%). Among women, the ASR increased in both groups, but more rapidly for HPV-related as compared to unrelated sites (APC over the period 2005-2012: +1.9% vs. -0.4%). This preferential growth of HPV-related versus unrelated HNC was observed in the cohorts born from 1930 to 1935. The differences in trends between possible HPV-related and HPV-unrelated sites suggest an increasing incidence of HNC due to HPV infection. The difference was less marked in men as compared to women, most likely because of a higher contamination in the HPV-related group by cancers due to tobacco or alcohol consumption. The pattern observed is consistent with observations made in other countries, with studies of HPV prevalence in HNC and the evolution of sexual behaviour in France.
人乳头瘤病毒(HPV)最近被认为是一部分头颈癌(HNC)的致癌因素。在欧洲,法国是头颈癌发病率最高的国家之一。本研究旨在探讨法国头颈癌发病率的变化,这可能与HPV感染有关。头颈癌被分为两个解剖学组:潜在HPV相关组和HPV非相关组。基于法国11个癌症登记处的数据,采用年龄-时期-队列模型分析了1980年至2012年期间的趋势。在男性中,两组头颈癌的年龄标准化发病率(ASR)均有所下降,但与非相关部位相比,HPV相关部位下降幅度较小,尤其是近年来(2005 - 2012年期间的年百分比变化[APC]:-3.5%对-5.4%)。在女性中,两组的ASR均有所上升,但与非相关部位相比,HPV相关部位上升得更快(2005 - 2012年期间的APC:+1.9%对-0.4%)。在1930年至1935年出生的队列中观察到了HPV相关头颈癌相对于非相关头颈癌的这种优先增长。可能的HPV相关部位和HPV非相关部位之间趋势的差异表明,HPV感染导致头颈癌发病率上升。与女性相比,男性的差异不太明显,这很可能是因为HPV相关组中因烟草或酒精消费导致的癌症污染程度更高。观察到的模式与其他国家的观察结果一致,也与法国头颈癌中HPV流行情况的研究以及性行为的演变一致。